Overview The protocol-specific research support resource is a mechanism for supporting innovative institutional investigator-initiated clinical trials that are deemed meritorious by the PRMS committee based on programmatic and scientific priorities, but which have insufficient support to meet their objectives. This resource is viewed as a means to support high quality translational research and encourage the development of clinical investigation. In the past, such investigations were supported in a limited manner by individual programs such as the Breast Center, the Center for Cell and Gene Therapy, the Prostate SPORE, and the Texas Children's Cancer Center. With the establishment of the Cancer Center, we anticipate that the number of such studies will increase both within the existing programs and in nascent programs such as the Gl and Gynecology efforts. Initially we estimate assisting with 2 or 3 projects per year, based on recommendation by the PRMS committee (see below for examples of the types of trials this resource would support). The Protocol-Specific resource is intimately associated with the CTSU as that facility is the support mechanism for research coordination and data management within the Cancer Center. Funds are requested for support of research coordination at each of the major Baylor-associated clinical sites, as we anticipate that these innovative trials will be offered at every site

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA125123-03
Application #
7900434
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
3
Fiscal Year
2009
Total Cost
$68,359
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Scavuzzo, Marissa A; Hill, Matthew C; Chmielowiec, Jolanta et al. (2018) Endocrine lineage biases arise in temporally distinct endocrine progenitors during pancreatic morphogenesis. Nat Commun 9:3356
Zhang, Yan; Zheng, Dayong; Zhou, Ting et al. (2018) Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers. Nat Commun 9:4080
Grzeskowiak, Caitlin L; Kundu, Samrat T; Mo, Xiulei et al. (2018) In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer. Nat Commun 9:2732
Liu, Yanhong; O'Brien, Jacqueline L; Ajami, Nadim J et al. (2018) Lung tissue microbial profile in lung cancer is distinct from emphysema. Am J Cancer Res 8:1775-1787
Newton, Jared M; Hanoteau, Aurelie; Sikora, Andrew G (2018) Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors. J Vis Exp :
Brunetti, Lorenzo; Gundry, Michael C; Sorcini, Daniele et al. (2018) Mutant NPM1 Maintains the Leukemic State through HOX Expression. Cancer Cell 34:499-512.e9
Zaheer, Mahira; Wang, Changjun; Bian, Fang et al. (2018) Protective role of commensal bacteria in Sjögren Syndrome. J Autoimmun 93:45-56
Wang, Xian; Tan, Ying; Cao, Xixi et al. (2018) Epigenetic activation of HORMAD1 in basal-like breast cancer: role in Rucaparib sensitivity. Oncotarget 9:30115-30127
Disney-Hogg, Linden; Sud, Amit; Law, Philip J et al. (2018) Influence of obesity-related risk factors in the aetiology of glioma. Br J Cancer 118:1020-1027
Szwarc, Maria M; Kommagani, Ramakrishna; Putluri, Vasanta et al. (2018) Steroid Receptor Coactivator-2 Controls the Pentose Phosphate Pathway through RPIA in Human Endometrial Cancer Cells. Sci Rep 8:13134

Showing the most recent 10 out of 991 publications